KOSPI · Healthcare · ₩640B
₩44,100+0.57%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 8.0% · as of 26.09.11
Among 5 제약 peers
Quarterly Revenue Growth
“전문 영역의 처방 기반이 꾸준한 성장을 받쳐주는 흐름이에요.”
In the company's words · 2026 2분기 filing